The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Until today this year the stock’s price performance recorded an increase of 83.23%. However, over the last six months, the performance has been weaker by 148.15%. The price of MOR increased 3.19% over the last 30 days. And in the last five days, it has surged by 0.61%.
Morphosys AG ADR saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $18.31 on 03/12/24, while the lowest price for the same duration was marked at $3.89 on 04/03/23.
52-week price history of MOR Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Morphosys AG ADR’s current trading price is -0.90% away from its 52-week high, while its distance from the 52-week low is 366.32%. The stock’s price range during this period has varied between$3.89 and $18.31. The Morphosys AG ADR’s shares, which operate in the Healthcare, saw a trading volume of around 0.28 million for the day, a figure considerably lower than their average daily volume of 2.11 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Morphosys AG ADR (MOR) has experienced a quarterly rise of 89.55% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.73B and boasts a workforce of 564 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 12.02, with a change in price of +10.62. Similarly, Morphosys AG ADR recorded 1,861,372 in trading volume during the last 100 days, posting a change of +141.22%.
MOR’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for MOR stands at 5.26. Similarly, the long-term debt-to-equity ratio is also 5.15.
MOR Stock Stochastic Average
Morphosys AG ADR’s raw stochastic average for the past 50 days is presently 98.25%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 80.24%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 81.84% and 82.63%, respectively.
